Papers by George Thanassoulis
Page 1 · newest first
- Hyperventilation-Induced Heart Rate Response as a Marker of Cardiovascular Risk - Large-Scale Validation from the Courtois Cardiovascular Signature Program2026
- Plasma Proteomic Biomarkers of Aortic StenosisJournal of the American College of Cardiology · 2024
- ASXL1- Mutant Clonal Hematopoiesis is Associated with Calcific Aortic Valve Disease and Promotes Valvular Calcification In Vitro2026
- Novel pharmacological targets for the treatment of aortic stenosisEuropean Heart Journal - Valvular and Structural Heart Disease · 2026
- Regulators of Mineralization and Long‐Term Progression of Aortic Valve and Mitral Annular Calcification: MESAJournal of the American Heart Association · 2026
- Does the evidence support the ACC/AHA Multisociety Recommendation to measure apoB only after LDL-C and non-HDL-C are at target?Journal of clinical lipidology · 2026
- Oxidized Phospholipids and Calcific Aortic Valvular DiseaseJournal of the American College of Cardiology · 2024
- Screening for High Lipoprotein(a)Circulation · 2019
- Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort EquationsJournal of the American College of Cardiology · 2022
- Sex Versus Gender-Related CharacteristicsJournal of the American College of Cardiology · 2016
- Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK BiobankEuropean Journal of Preventive Cardiology · 2026
- Lipoprotein(a), Carotid Intima–Media Thickness, and Atherosclerotic Cardiovascular DiseaseAmerican Journal of Preventive Cardiology · 2026
- Clinical Risk Assessment and Prediction in Congenital Heart Disease Across the LifespanJournal of the American College of Cardiology · 2024
- Old and New Lines of Therapy Targeting Lipoprotein(a)Current Atherosclerosis Reports · 2026
- Rationale and Design of the Canadian Lipoprotein(a) RegistryCJC Open · 2026
- Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic StenosisJournal of the American College of Cardiology · 2024
- Trajectories of Non–HDL Cholesterol Across MidlifeJournal of the American College of Cardiology · 2019
- Association of Polygenic Risk Scores With Aortic Valve Calcium: The Multi‐Ethnic Study of AtherosclerosisJournal of the American Heart Association · 2026
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic StenosisJournal of the American College of Cardiology · 2018
- Poor Performance of LDL-Cholesterol Equations versus Beta Quantification in a Very Large Cohort of Patients with DyslipidemiaClinical Chemistry · 2026
- Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide studyEuropean Heart Journal · 2023
- Sex-Specific Prognostic Value of Aortic Valve Calcium and the Risk for Aortic Stenosis: Multi-Ethnic Study of Atherosclerosis (MESA)Circulation Cardiovascular Imaging · 2026
- Sex-Focused Evaluation of Income and Education and the Risk of Atherosclerotic Cardiovascular Diseases Within a Universal Healthcare Context.CJC Open · 2026
- ApoA-1 versus HDL-C as Markers of Cardiovascular RiskJournal of clinical lipidology · 2026
- Race and Ethnic-Specific Burden of Aortic Valve Calcium and Its Association With Long-Term Aortic Stenosis: Multi-Ethnic Study of AtherosclerosisCirculation Cardiovascular Imaging · 2026
- Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of AtherosclerosisEuropean Heart Journal · 2026
- Impact of Age on Aortic Valve Calcium Progression and Risk for Aortic Stenosis: Multi-Ethnic Study of AtherosclerosisEuropean Heart Journal - Cardiovascular Imaging · 2025
- Aortic Atherosclerosis Detection on Transesophageal Echocardiography is Associated with Left Atrial Appendage Thrombus in Low Thromboembolic Risk PatientsArrhythmia & Electrophysiology Review · 2025
- ApoA-1 versus HDL-C as Markers of Cardiovascular Risk2025
- Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisAtherosclerosis · 2025
- Myocardial compression and recoil as determinants of coronary blood flow.2025
- Rationale for the routine screening of Lipoprotein(a) in cardiovascular risk assessmentEuropean Journal of Preventive Cardiology · 2025
- The Brussels International Declaration on Lipoprotein(a) Testing and ManagementAtherosclerosis · 2025
- Plasma Proteomic Assessment of Calcific Aortic Valve Disease in Older AdultsSHILAP Revista de lepidopterología · 2025
- A Multidisciplinary Aortopathy Clinic: The McGill ExperienceCJC Open · 2025
- Hemoglobin A1c and abdominal obesity as predictors of diabetes and ASCVD in individuals with prediabetes in UK Biobank: a prospective observational studyCardiovascular Diabetology · 2024
- Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery DiseaseJAMA Cardiology · 2024
- Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational StudyArteriosclerosis Thrombosis and Vascular Biology · 2024
- Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid GuidelineCJC Open · 2024
- Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein CholesterolCirculation Cardiovascular Imaging · 2024
- Implications of five different risk models in primary prevention guidelinesEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2024
- Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular preventionEuropean Heart Journal · 2024
- The Causal-Benefit Model to Prevent Cardiovascular EventsJACC Advances · 2024
- Atherothrombotic and thrombolytic biomarkers in incident stroke and atrial fibrillation-related stroke: The Multi-Ethnic Study of Atherosclerosis (MESA)Atherosclerosis · 2024
- Updated Lipoprotein(a) Genomic Risk Score and Aspirin for Primary Prevention of Cardiovascular EventsJACC Advances · 2023
- Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular DiseaseAnnals of Internal Medicine · 2023
- Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart DiseaseCirculation · 2023
- Validation of the European SCORE2 models in a Canadian primary care cohortEuropean Journal of Preventive Cardiology · 2023
- P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activationJournal of Hypertension · 2023
- Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of CalcificationCirculation · 2023